Saturday 7 November 2026
Export ELV’s income statement to Excel — free account
Elevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
425.62
6.38
−1.48%
Follow ELV
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | 6 |
| 13.25% | 12.10% | 11.17% | 11.56% | ||
| 4.75% | 4.27% | 4.00% | 4.10% | ||
ROIC |
12.74% | 12.52% | 11.83% | 12.76% | |
Return on Tangible Assets |
21.25% | 19.87% | 18.00% | 19.41% | |
Average Days of Receivables |
39.49 | 41.51 | 42.45 | 44.44 | |
Free Cash Flow per Share |
14.17 | 29.34 | 28.98 | 30.07 | |
Free Cash Flow |
3,174.00 | 6,450.00 | 6,289.00 | 6,514.00 | |
Capital Expenditures |
(1,116.00) | (1,155.00) | (1,175.00) | (1,082.00) | |
| Other line items | |||||
Cash ROIC |
2.83% | 5.75% | 5.54% | 5.74% | |
Accounts Receivable Turnover |
9.81 | 8.91 | 8.65 | 8.60 | |
Accounts Payable Turnover |
7.20 | 7.01 | 6.89 | 6.83 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
52.59 | 52.83 | 53.66 | 57.24 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.16) | (0.16) | (0.16) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.14% | 0.12% | 0.12% | 0.12% | |
Interest Coverage |
5.79 | 5.39 | 5.08 | 5.33 | |
Operating CF/Net income |
0.76 | 1.45 | 1.50 | 1.48 | |
Depreciation/Fixed assets |
0.33 | 0.33 | 0.33 | 0.32 | |
Capex/Depreciation |
(0.72) | (0.76) | (0.78) | (0.73) | |
Revenue per Share |
888.95 | 911.81 | 926.79 | 931.81 | |
Operating CF per Share |
19.15 | 34.60 | 34.40 | 35.07 | |
Capex per Share |
(4.98) | (5.25) | (5.41) | (5.00) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 2 Nov 2026